SOMERSET, N.J., May 25, 2023 /PRNewswire/ -- Catalent (NYSE:CTLT), the leader in enabling the devel...
SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, ge...
SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced del...
SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supp...